EPITALON
Circadian Research Research · 10mg
Size: 10mg
With code SPOOKY
35% off sitewide with code SPOOKY — apply it in your cart
Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled on epithalamin, a pineal gland extract. This compound is supplied lyophilized for laboratory preparation of solutions used in preclinical investigations of telomerase activity, telomere biology and circadian regulation in model systems.
For Research Purposes Only.
Research Use Notes
Supplied as lyophilized powder
Requires reconstitution before use
Research Water required for mixing (sold separately)
Swirl gently, never shake
Storage
Store lyophilized powder vial in freezer
Keep at 2 to 8°C
Protect from light and heat
After mixing, keep refrigerated
Use within typical research handling window after reconstitution
Handling
Use sterile technique during reconstitution
For laboratory research use only
Certificate of Analysis
Every batch is independently third-party tested before it ships.
- Strength
- 10MG
- Form
- Lyophilized powder
- Testing
- Third-party, batch-specific
All certificates are issued by independent ISO-accredited laboratories. Lot-specific documents are made available to qualified research professionals on request.
Frequently Bought Together
Commonly paired to support consistent, reliable experimentation.
Compound Information
Technical specifications
What Is EPITALON?
Circadian Research Research · 10mg
- SKU
- 025
- Category
- Circadian Research, Compounds
- Strength
- 10MG
- Also known as
- Epitalon · AEDG (Ala-Glu-Asp-Gly)
- Type
- Synthetic tetrapeptide
- CAS Number
- 307297-39-8
- Molecular Weight
- 390.35 g/mol
- Form
- Lyophilized powder
- Sizes
- 10mg
Stability Information
-20°C
24+ months
2-8°C
~30 days
Products are intended solely for laboratory and scientific research purposes. Not intended for human consumption, veterinary use, diagnosis, treatment, cure, or prevention of disease.
All the research compounds you need, with the confidence that every batch is 7× tested before it ships.
Subscribe to our Newsletter
Subscribe to our newsletter to get daily insights, news, updates.